Literature DB >> 35020059

A high-volume ERCP service led by surgeons is associated with good outcomes and meets national key performance indicators: results from a British district general hospital.

Henry D De'Ath1, Sathyan Nagendram2, Eleanor Smith2, Mohamed Ramadan2, Darmarajah Veeramootoo2, Sukhpal Singh2.   

Abstract

BACKGROUND: Endoscopic retrograde cholangiopancreatography (ERCP) is a common, but technically challenging procedure used in the management of hepatopancreaticobiliary (HPB) disease. It is traditionally performed by medical gastroenterologists. In 2014, the British Society of Gastroenterology (BSG) proposed key performance indicators to evaluate and set standards of ERCP practice. This study aimed to compare our ERCP outcomes against these targets, in a centre where ERCP is exclusively performed by surgeons.
METHODS: A retrospective analysis of all ERCPs undertaken over a 38 months in a District General Hospital in the United Kingdom (UK), by three Upper Gastrointestinal Surgeons. Study outcomes were based upon, and compared against, BSG key performance indicators, including number of ERCPs per annum, proportion of successful cannulations of bile duct and stone clearance, ERCP-specific complications and mortality.
RESULTS: The unit's caseload over this period was 1324, equating to approximately 418 per annum (BSG minimum 200 per unit). Management of bile duct stones was the commonest indication for ERCP. Overall, 95% (1253/1324) of bile ducts were cannulated and 92% (645/698) for those undergoing their first ERCP. Bile duct clearance was achieved in 80% of patients (BSG recommend > 75%) and the successful stenting of extra-hepatic strictures in 94% (BSG recommend > 80%). The overall complication rate was 4.3% (BSG standard < 6%). Procedure-specific mortality was 0.3% (4/1324) where death was either caused by pancreatitis or sepsis.
CONCLUSION: A high-volume ERCP service led and performed exclusively by surgeons meets all BSG performance indicators, with good procedural and patient outcomes. Formal training pathways should be developed to encourage more surgical centres to provide an ERCP service and deal with what are common surgical pathologies.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  ERCP; Outcomes; Quality indicators; Surgical endoscopy

Mesh:

Year:  2022        PMID: 35020059     DOI: 10.1007/s00464-021-08978-x

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   3.453


  19 in total

1.  Provision of ERCP services and training in the United Kingdom.

Authors:  M C Allison; D N Ramanaden; M G Fouweather; D K Davis; D G Colin-Jones
Journal:  Endoscopy       Date:  2000-09       Impact factor: 10.093

2.  Relationship among hospital ERCP volume, length of stay, and technical outcomes.

Authors:  Shyam Varadarajulu; Meredith L Kilgore; Charles M Wilcox; Mohamad A Eloubeidi
Journal:  Gastrointest Endosc       Date:  2006-09       Impact factor: 9.427

3.  Nationwide, population-based data from 11,074 ERCP procedures from the Swedish Registry for Gallstone Surgery and ERCP.

Authors:  Lars Enochsson; Fredrik Swahn; Urban Arnelo; Magnus Nilsson; Matthias Löhr; Gunnar Persson
Journal:  Gastrointest Endosc       Date:  2010-12       Impact factor: 9.427

4.  Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study.

Authors:  S Loperfido; G Angelini; G Benedetti; F Chilovi; F Costan; F De Berardinis; M De Bernardin; A Ederle; P Fina; A Fratton
Journal:  Gastrointest Endosc       Date:  1998-07       Impact factor: 9.427

Review 5.  Association Between Endoscopist and Center Endoscopic Retrograde Cholangiopancreatography Volume With Procedure Success and Adverse Outcomes: A Systematic Review and Meta-analysis.

Authors:  Rajesh N Keswani; Bashar J Qumseya; Linda C O'Dwyer; Sachin Wani
Journal:  Clin Gastroenterol Hepatol       Date:  2017-06-10       Impact factor: 11.382

6.  Trends in utilization of diagnostic and therapeutic ERCP and cholecystectomy over the past 25 years: a population-based study.

Authors:  Dana C Moffatt; B Nancy Yu; Wiechun Yie; Charles N Bernstein
Journal:  Gastrointest Endosc       Date:  2013-10-08       Impact factor: 9.427

7.  Endoscopic cannulation of the ampulla of vater: a preliminary report.

Authors:  W S McCune; P E Shorb; H Moscovitz
Journal:  Ann Surg       Date:  1968-05       Impact factor: 12.969

8.  ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) Guideline.

Authors:  Jean-Marc Dumonceau; Christine Kapral; Lars Aabakken; Ioannis S Papanikolaou; Andrea Tringali; Geoffroy Vanbiervliet; Torsten Beyna; Mario Dinis-Ribeiro; Istvan Hritz; Alberto Mariani; Gregorios Paspatis; Franco Radaelli; Sundeep Lakhtakia; Andrew M Veitch; Jeanin E van Hooft
Journal:  Endoscopy       Date:  2019-12-20       Impact factor: 10.093

Review 9.  Indomethacin and diclofenac in the prevention of post-ERCP pancreatitis: a systematic review and meta-analysis of prospective controlled trials.

Authors:  Árpád Patai; Norbert Solymosi; László Mohácsi; Árpád V Patai
Journal:  Gastrointest Endosc       Date:  2017-02-04       Impact factor: 9.427

Review 10.  How and when should NSAIDs be used for preventing post-ERCP pancreatitis? A systematic review and meta-analysis.

Authors:  Ignasi Puig; Xavier Calvet; Mireia Baylina; Álvaro Isava; Pau Sort; Jordina Llaó; Francesc Porta; Francesc Vida
Journal:  PLoS One       Date:  2014-03-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.